Korelasi Kadar Serum Tumor Necrosis Factor Alpha (TNF α) dan Matriks Metalloproteinase-9 (MMP-9) pada Pasien Gastritis H.Pylori dan Non H.Pylori
DAFTAR PUSTAKA
1.
El-Zimaity HMT. Recent advances in the histopathology of gastritis. Current
Diagnostic Pathology. 2007;13:340-8.
2.
Rugge M, Genta RM. Staging and grading of chronic gastritis. Human
pathology. 2005;36:228-33.
3.
Fox JG, Megraud F. Helicobacter. In: Murray PR, editor. Manual of clinical
microbiology. 9th ed. Pensylvania: Elsevier Mosby; 2007. hlm.947-62.
4.
Cesar ACG, Cury PM, Payao SLM. Comparison of histological and
molecular diagnosis of Helicobacter pylori in benign lesions and gastric
adenocarcinoma. Braz J Microbiol. 2005;36(1):261-6.
5.
Banerjee A, Mukhopadhyay AK, Paul S, Bhattacharyya A and Swarnakar S.
Unveiling
the
Intricacies
of
Helicobacter
pylori-induced
Gastric
Inflammation: T Helper cells and Matrix Metalloproteinases at a Crossroad.
In: Mozsik G, editor. Current Topics in Gastritis. Croatia: InTech Publishers;
2013. Chapter 7.
6.
Rehnberg-Laiho L, Rautelin H, Koskela P, Sarna S, Pukkala E, Aromaa A, et
al. Decreasing prevalence of helicobacter antibodies in Finland, with
reference to the decreasing incidence of gastric cancer. Epidemiol Infect.
2001;126:37-42.
7.
Matsukura N, Yamada S, Kato S, Tomtitchong P, Tajiri T, Miki M, et al.
Genetic differences in interleukin-1 betapolymorphisms among four Asian
populations: an analysis of the Asian paradox between H. pylori infection and
gastric cancer incidence. J Exp Clin Cancer Res. 2003; 22: 47-55.
8.
Xuan J, Deguchi R, Yanagi H, Ozawa H, Urano T, Ogawa Y, et al.
Relationship between gastric mucosal IL-8 levels and histological gastritis in
patients with Helicobacter pylori infection. Tokai J Exp Clin Med.
2005;30(2):83-8.
9.
Andersen LP, Holck S, Janulaityte-Gu¨nther D, Kupcinskas L, Kiudelis G,
Jonaitis L, et al. Gastric inflammatory markers and interleukins in patients
Universitas Sumatera Utara
with functional dyspepsia, with and without Helicobacter pylori infection.
FEMS Immunology and Medical Microbiology.2005;44:233–8.
10. Koskensalo S, Mrena J, Wiksten JP, Nordling S, Kokkola A, Hagstrom J, et
al, 2010. MMP-7 overexpression is an independent prognostic marker in
gastric cancer. Tumor Biol. (2010) 31: 149-155
11. Caruso R, Fina D, Peluso I, Tosti C, Blanco GDV, et al. IL-21Is Highly
Produced in Helicobacter pylori- Infected Gastritis Mucosa and Promotes
Gelatinases Synthesis J Immunol 2007;178: 5957-5965
12. Zhang Qiong-Wen, Liu Lei, Chen Ru, Wei Yu-Quan , Li Ping, Shi Hua-Shan
,
Zhao Yu-Wei.: Matrix Metalloproteinase-9 as a Prognostic Factor in Gastric
Cancer: A Meta-Analysis. Asian Pacific Journal of Prevention,vol 13,2012. P
2903-2908
13. Rhee Jae Won, Lee Keun-Wook, Kim Dongbum , Lee Younghee, Jeon OkHee,
Kwon Hyung-Joo , Kim Doo-Sik : 94 NF-κB-dependent Regulation of Matrix
Metalloproteinase-9 Gene Expression by Lipopolysaccharide in a Macrophage
Cell Line RAW 264.7. Journal of Biochemistry and Molecular Biology, Vol.
40, No. 1, January 2007, pp. 88-94
14. Toljamo K. Gastric erosions – clinical significance and pathology. A longterm follow-up study. University of Oulu, Finland:Acta Univ Oul; 2012.hlm
1-80.
15. Hirlan, Gastritis dalam Buku Ajar Ilmu Penyakit Dalam Edisi 5, Internal
Publishing : 2009 ; 509-512
16. S Iiyas. Repository.usu.ac.id.2013
17. Szoke D. Genetic factors related to the histological and macroscopic lesions
of the stomach. [disertasi]. Budapest: Semmelweis University; 2009. Hlm 761
18. Wehbi M. Acute gastritis. Medscape. 2014
Universitas Sumatera Utara
19. Rugge M, Pennelli G, Pilozzi E, Fassan M, Ingravallo G, Russo VM, et al.
Gastritis: the histology report. Digestive and Liver Disease. 2011; 43S:S373–
84.
20. Adibi P. Gastritis. [Diunduh 19 Mei 2014]. Tersedia dari: http://med.mui.ac.ir
21. Zakaria Z. The role of interleukin-10 in Helicobacter pylori infection. Master
[Tesis]. Nottingham,UK: University of Nottingham; 2010.hlm. 55.
22. Adam B, et al. Cellular immune activation and clinical manifestation of
funcional dyspepsia. Z Gastroenterol 2008;46-v26
23. Elseweidy MM. Helicobacter pylori ifection and its relevant to chronic
gastritis. INTECH.2013.http://dx.doi.org/105772/46056
24. Conteduca vincenza, domenico sansonno, gianfranco lauletta, sabino russi,
giuseppe ingravallo and franco dammacco. H. pylori infection and gastric
cancer: State of the art. international journal of oncology. 2013.42: 5-18.
25. D W, Chey, C B, Wong. American college of gastroenterology guidline on
the management of H.pylori infetion. Am J Gastroenterol 2007;102:18081825.
26. Simadibrata M. Dyspepsia and Gastroesophageal Reflux Disease (GERD): Is
There Any Correlation? Acta Med Indones. 2009; 41(4): 222-7.
27. Silva MIG, de Sousa FCF. Gastric ulcer etiology. In: Chai J, editor. Peptic
Ulcer Disease. Shanghai: Intech; 2011. hlm. 3-28.
28. Syam AF, Sadikin M, Wanandi SI, Rani AA. Molecular mechanism on
healing process of peptic ulcer. Acta Med Indones. 2009;41(2):95-8.
29. Brzozowski T. Experimental production of peptic ulcer, gastric damage and
cancer
models
pharmacological
and
their
use
treatment–polish
in
pathophysiological
achievement.
J
Phyl
studies
and
Pharmacol.
2003;54:99-126
30. Cheung R, Cheng TT, Dong Y, Lin HY, Lai K, Lau CS, et al. 2010. Incidence
of gastroduodenal ulcers during treatment with celecoxib or diclofenac:
pooled results from three 12-week trials in Chinese patients with osteoarthritis
or rheumatoid arthritis. Int J Rheum Dis;13(2): 151–7.
Universitas Sumatera Utara
31. Wallace JB. Prostaglandins, NSAIDs, and Gastric Mucosal Protection: Why
Doesn’t the Stomach Digest Itself? American Physiological Society. Physiol
Rev 88: 1547-1565, 2008Zhao X, Wang Q, Qian Y, Song JL,. Ilex kudingcha
C.J. Tseng (Kudingcha) prevents HCl/ethanol induced gastric injury in
Sprague Dawley rats. Molecular Medicine Reports. 2013;7:1613-6.
32. Mueller, A., et al., Profiling of microdissected gastric epithelial cells reveals
a
cell
type—specific
response
to
Helicobacter
pylori
infection.
Gastroenterology, 2004. 127(5): p. 1446-1462.
33. Fischer, W., et al., Systematic mutagenesis of the Helicobacter pylori cag
pathogenicity island: essential genes for CagA translocation in host cells and
induction of interleukin‐8. Molecular Microbiology, 2003. 47(6): p. 17591759.
34. Sundrud, M.S., et al., Inhibition of primary human T cell proliferation by
Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects
on IL-2 secretion. Proceedings of the National Academy of Sciences of the
United States of America, 2004. 101(20): p. 7727-7732.
35. Pelicic V, Reyrat JM, Sartori L, Pagliaccia C, Rappuoli R, Telford JL, et al.
Helicobacter pylori VacA cytotoxin associated with the bacteria increases
epithelial
permeability
independently
of
its
vacuolating
activity.
Microbiology. 1999;145(8): 2043-50.
36. Lu, H., et al., Duodenal ulcer promoting gene of Helicobacter pylori.
Gastroenterology, 2005. 128(4): p. 833-848.
37. Yamaoka, Y., et al., Helicobacter pylori outer membrane proteins and
gastroduodenal disease. Gut, 2006. 55(6): p. 775-781.
38. Rad, R., et al., The Helicobacter pylori blood group antigen-binding adhesin
facilitates bacterial colonization and augments a nonspecific immune
response. The Journal of Immunology, 2002. 168(6): p. 3033-3041.
39. Montecucco, C. and M. de Bernard, Molecular and cellular mechanisms of
action of the vacuolating cytotoxin (VacA) and neutrophil-activating protein
(HP-NAP) virulence factors of Helicobacter pylori. Microbes and infection,
2003. 5(8): p. 715-721.
Universitas Sumatera Utara
40. Chung HW, Lim JB, 2014. Role of the tumor microenvironment in the
pathogenesis of gastric carcinoma. World J Gastroenterol 2014; 20(7): 16671680
41. Tarnawski AS, Chai J, Jones MK. Esophageal and Gastrointestinal
Microcirculation: Essential for Mucosal Protection, a Target for Injury, and a
Critical Component of Injury and Ulcer Healing. In: Ishii H, Suematsu M,
Tanishita K, editor. Organ microcirculation: a gateway to diagnostic and
therapeutic intervention. Tokyo: Springer; 2005. Hlm 49-61.
42. Zhao X, Wang Q, Qian Y, Song JL,. Ilex kudingcha C.J. Tseng (Kudingcha)
prevents HCl/ethanol induced gastric injury in Sprague Dawley rats.
Molecular Medicine Reports. 2013;7:1613-6.
43. Tanigawa T, Watanabe T, Higuchi K, Machida H, Okazaki H, Yamagami H,
Watanabe K, Tominaga K, Fujiwara Y, Oshitani N, et al: Lansoprazole, a
Proton Pump Inhibitor, Suppresses Production of Tumor Necrosis
Factoralpha and Interleukin-1beta Induced by Lipopolysaccharide and
Helicobacter Pylori Bacterial Components in Human Monocytic Cells via
Inhibition of Activation of Nuclear Factor-kappaB and Extracellular SignalRegulated Kinase. J Clin Biochem Nutr. 2009, 45(1):86–92.
44. Lee HJ, Han YM, Kim EH, Kim YJ, Hahm KB. A possible involvement of
Nrf2-mediated heme oxygenase-1 up-regulation in protective effect of the
proton pump inhibitor pantoprazole against indomethacin-induced gastric
damage in rats. BMC Gastroenterology. 2012;12:143Bradley JR. TNFmediated inflammatory disease. J Pathol. 2008; 214:149-60.
45. Rakananurak N, Sallapant S, Prueksapanich P, Somanawat K, Klaikaew N,
Rerknimitr R, et al. Aloe vera Improved Gastric Injury on Nonsteroidal AntiInflammatory Drugs-Induced Gastropathy in Rats. Thai J Gastroenterol.
2013; 14(2):87-92.
46. Eamlamnam K, Patumraj S, Visedopas N, et al. Effects of Aloe vera and
sucralfate on gastric microcirculatory changes, cytokine levels and gastric
ulcer healing in rats. World J Gastroenterol. 2006;12:2034-9.
Universitas Sumatera Utara
47. Naito Y, Yoshikawa T, Yagi N, Matsuyama K, Yoshida N, Seto K, et al.
Effects of polaprezinc on lipid peroxidation, neutrophil accumulation, and
TNF- expression in rats with aspirin-induced gastric mucosal injury. Dig Dis
Sci. 2001;46:845–51.
48. Jainu M, Devi CSS. Gastroprotective action of Cissus quadrangularis extract
against NSAID induced gastric ulcer: role of proinflammatory cytokines and
oxidative damage. Chem Biol Interact. 2006;161:262–70
49. Konturek PC, Duda A, Brzozowski T, Konturek SJ, Kwiecien S, Drozdowicz
D, et al. Activation of genes for superoxide dismutase, interleukin-1beta,
tumor necrosis factor-alpha, and intercellular adhesion molecule-1 during
healing of ischemia-reperfusion-induced gastric injury. Scand J Gastroenterol.
2000;35(5):452-63
50. Fox JG, Wang TC. Inflammation, atrophy and gastric cancer. The Journal of
Clinical
51. Israel DA, Peek RM. Review article: Pathogenesis of Helicobacter pyloriinduced gastric inflammation. Aliment Pharmacol Ther. 2001;15:1271-90.
52. Bodger K, Crabtree JE. Helicobacter pylori and gastric inflammation. British
Med Bull. 1998;54:139-50
53. Furuta T, El-Omar EM, Xiao F, Shirai N, Takashima M, Sugimura H.
Interleukin 1beta polymorphisms increase risk of hypochlorhydria and
atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan.
Gastroenterology. 2002;123(1):92-105
54. Holck S, Norgaard A, Bennedsen M, Permin H, Norn S, Andersen LP, et al.
Gastric mucosal cytokine responses in Helicobacter pylori-infected patients
with gastritis and peptic ulcers. Association with inflammatory parameters
and bacteria load. FEMS Immunology and Medical Microbiology.
2003;36:175-80.
55. Schottelius AJ, Mayo MW, Sartor RB, Baldwin AS. Interleukin-10 signaling
blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA
binding. J Biol Chem. 1999;274:31868-74
Universitas Sumatera Utara
56. Al-Ashy R, Chakroun I, El-Sabban ME, Homaidan FR. The role of NFkappaB in mediating the anti-inflammatory effects of IL-10 in intestinal
epithelial cells. Cytokine. 2006; 36:1-8.
57. Kriskova S, Zitka O, Masarik M et al. Clinical Importance of matrix
metalloproteinases. Bratisl Lek Listy 2011;112(8):435-440
58. Amalinei C, Caruntu ID, Giusca SE et all. Matrix metalloproteinases
involvement in pathologic conditions. Romanian Journal of Morphology and
Embryology 2010, 51(2):215–228.
59. Verma RP,
Hansch C. Matrix metalloproteinases (MMPs): Chemical–
biological functions and (Q)SARs. Bioorganic & Medicinal Chemistry.
Volume 15, Issue 6, 15 March 2007, Pages 2223–2268.
60. Angulo JC, Ferruelo A, Barbero JMR et al. Detection and molecular staging
of bladder cancer using real-time RT-PCR for gelatinases (MMP-2, MMP-9)
and TIMP-2 in peripheral blood. Actas Urológicas Españolas (English
Edition). Volume 35, Issue 3, 2011,127–136.
61. Sampieri CL, Cordoba KL, Troche JMR, 2013.Matrix metalloproteinases and
their tissue inhibitors in gastric cancer as molecular markers. Review
Article.Journal of Cancer Research and Therapeutics, 2013.Volume 9-Issue 3.
62. Decocks J, Paridaens R, Ye S. Genetic polymorphisms of matrix
metalloproteinases in lung, breast and colorectal cancer. Clinical Genetics,
An International Journal of Genetics, Molecular and Personalized Medicine.
Volume 73, Issue 3, pages 197–211, March 2008
63. Charoenrat PO, Rhys-Evans PH, Eccles SA. Expression of Matrix
Metalloproteinases and Their Inhibitors Correlates With Invasion and
Metastasis in Squamous Cell Carcinoma of the Head and Neck. Arch
Otolaryngol Head Neck Surg. 2001;127(7):813-820
64. Mairi Macarthur, Georgina L. Hold, and Emad M. El-Omar. 2004.
Inflammation and Cancer. II. Role of chronic inflammation and cytokine gene
polymorphisms in the pathogenesis of gastrointestinal malignancy. Am J
Physiol
Gastrointest
Liver
Physiol
286:
G515-G520,
2004;
10.1152/ajpgi.00475.2003
Universitas Sumatera Utara
65. Musumba C, Pritchard DM, Primohamed M : Cellular and molecular
mechanisms of NSAID-induces peptic ulcers. Alimentary Pharmacology and
Therapeutics 30,2009. Blackwell Publishing . p517-531
66. Detrick, B., C. Nagineni, and J. Hooks, Cytokines: Regulators of Immune
Responses and Key Therapeutic Targets In: MRGOGaAD Donnenberg.
Human Immunology, CRC Press, Taylor & Francis Group, 2008: p. 495-516
67. Baratawidjaja KG. Imunologi Dasar: Sitokin. Jakarta: Balai Penerbit FK-UI;
2004. hlm. 128-31
68. Bradley JR. TNF-mediated inflammatory disease. J Pathol. 2008; 214:149-60.
69. Genersch Elke, Hayeß Katrin, Neuenfeld Yvette and Haller Hermann.
Sustained ERK phosphorylation is necessary but not sufficient for MMP-9
regulation in endothelial cells: involvement of Ras-dependent andindependent pathways. Journal of Cell Science 113, 4319-4330 (2000) 4319
Printed in Great Britain © The Company of Biologists Limited 2000
JCS1673
70. Amieva MR, Salama NR, Tompikns LS and Falkov S. Helicobacter pylori
Enter and Survive within Multivesiculer Vacuoles of Ephithelial Cells.
Cellular Mikrobiology. 2002; 4(10):677
71. Visse R and Nagase H. Matrix Metalloproteinase and Tissue Inhibitors of
Metalloproteinase;
Stucture,
Function,
and
Biochemistry.
Circulation
Research. 2003;8:827-839
72. Gibbs D.F. Warner R.L. , Weiss S. J., Johnson K.J., Varani J. 1999.
Characterization of Matrix Metalloproteinases Products by Rat Alveolar
macrophages . Am.J. Respir. Cell Moll . Biol. 20(6), 1136-1144.
73. Garg B, Sandhu V, Sood N, Sood A, Malhotra V. Histopathological analysis
of chronic gastritis and correlation of pathological features with each other
and with endoscopic findings. Pol J Pathol. 2012;3:172-8.
74. Chen H, Ying L, Kong M, Zhang Y, Li Y. The Prevalence of Helicobacter
pylori
Infection
Decreases
Gastritis. Gastroenterology
with
Older
Research
Age
and
in
Atrophic
Practice.
2013:Aug;21(2013)http://dx.doi.org/10.1155/2013/494783
Universitas Sumatera Utara
75. Pandeya N, Whiteman DC, Australian Cancer Study. Prevalence and
determinants of Helicobacter pylori sero-positivity in the Australian adult
community. J Gastroenterology Hepatology.2011 ;Aug;26(8):1283-9
76. Betty. Infeksi Helicobacter pylori pada lesi gastritis yang didiagnosa dengan
Pewarnaan Histokimia Giemsa dan Imunohistokimia Helicobacter pylori di
Laboratorium Patologi Anatomi Fakultas Kedokteran USU Medan. 2012.
http://repository.usu.ac.id/handle/123456789/34694
77. Parameswaran I, Hubungan peningkatan kadar leukosit dan neutropil dengan
infeksi
H.pylori
di
RSU
Permata
Bunda
Medan.2014.
http://repository.usu.ac.id/handle/123456789/41610.
78. Zho Y, et al. Risk factors and prevalence of H.Pylori infection in persistent
high incidence area of gastric carcinoma in Yangzhong city.2014.
http://dx.doi.org/10.1155/2014/481365
79. Naja F,et al. Helicobacter pylori in Ontario : prevalence and rsik factors.Jurnal
canadian of gastroenterologi. 2007:21(8):501-506
80. Abidiev S, Ahn KS, Khadjibaev A, Malikov Y, Bahramov S, Rakhimov B, et
al. Helicobacter pylori infection and cytokine gene polymorphisms in Uzbeks.
Nagoya J Med Sci, 2010;72:167-72
81. Salama NR, Hartung ML, Müller Anne. Life in the human stomach:
persistence strategies of the bacterial pathogen Helicobacter pylori. Nature
Reveiws Microbiol. 2013;11:385-99
82. Hoyer KK, Dooms H, Barron L, Abbas AK. Interleukin-2 in the development
and control of inflammatory disease. Immun Reviews. 2008; 226:19-28
83. Bamford KB, Fan X, Crowe SE, Leary JF, Gourley WK, Luthra GK, et al.
Lymphocytes in the human gastric mucosa during Helicobacter pylori have a
T helper cell 1 phenotype. Gastroenterol, 1998;114(3):482-92.
84. F.J.G.M. Kubben, C.F.M. Sier, M. Schram, A.M.C. Witte1, R.A. Veenendaal,
W. van Duijn, J.H. Verheijen, R. Hanemaaijer, C.B.H.W. Lamers, H.W.
Verspaget. Eradication of Helicobacter pylori infection favourably a ects
altered gastric mucosal MMP-9 levels. TNO Quality of Life, Biomedical
Research, Leiden, The Netherlands. Chapter 3. Helicobacter 2007, in press
Universitas Sumatera Utara
85. Adam B, et al. Cellular immune activation and clinical manifestation of
funcional dyspepsia. Z Gastroenterol 2008;46-v26
86. Joshi A, Gupta SD, Ahuja V, Sharma MP. Symptom score does not correlate
with gastritis grade and Helicobacter pylori infection in non ulcer dyspepsia.
Trop Gastroenterol 2001;22:194-6.
87. Sen Lin Li, Jing Run Zhao, Xiao Yan Ren, Jia Ping Xie, Qing Zhu Ma, Qiu
Hua Rong. Increased expression of matrix metalloproteinase-9 assosiated with
gastric ulcer recurren. World J Gastroenterol 2013;(28)19:4590-5.
Universitas Sumatera Utara
1.
El-Zimaity HMT. Recent advances in the histopathology of gastritis. Current
Diagnostic Pathology. 2007;13:340-8.
2.
Rugge M, Genta RM. Staging and grading of chronic gastritis. Human
pathology. 2005;36:228-33.
3.
Fox JG, Megraud F. Helicobacter. In: Murray PR, editor. Manual of clinical
microbiology. 9th ed. Pensylvania: Elsevier Mosby; 2007. hlm.947-62.
4.
Cesar ACG, Cury PM, Payao SLM. Comparison of histological and
molecular diagnosis of Helicobacter pylori in benign lesions and gastric
adenocarcinoma. Braz J Microbiol. 2005;36(1):261-6.
5.
Banerjee A, Mukhopadhyay AK, Paul S, Bhattacharyya A and Swarnakar S.
Unveiling
the
Intricacies
of
Helicobacter
pylori-induced
Gastric
Inflammation: T Helper cells and Matrix Metalloproteinases at a Crossroad.
In: Mozsik G, editor. Current Topics in Gastritis. Croatia: InTech Publishers;
2013. Chapter 7.
6.
Rehnberg-Laiho L, Rautelin H, Koskela P, Sarna S, Pukkala E, Aromaa A, et
al. Decreasing prevalence of helicobacter antibodies in Finland, with
reference to the decreasing incidence of gastric cancer. Epidemiol Infect.
2001;126:37-42.
7.
Matsukura N, Yamada S, Kato S, Tomtitchong P, Tajiri T, Miki M, et al.
Genetic differences in interleukin-1 betapolymorphisms among four Asian
populations: an analysis of the Asian paradox between H. pylori infection and
gastric cancer incidence. J Exp Clin Cancer Res. 2003; 22: 47-55.
8.
Xuan J, Deguchi R, Yanagi H, Ozawa H, Urano T, Ogawa Y, et al.
Relationship between gastric mucosal IL-8 levels and histological gastritis in
patients with Helicobacter pylori infection. Tokai J Exp Clin Med.
2005;30(2):83-8.
9.
Andersen LP, Holck S, Janulaityte-Gu¨nther D, Kupcinskas L, Kiudelis G,
Jonaitis L, et al. Gastric inflammatory markers and interleukins in patients
Universitas Sumatera Utara
with functional dyspepsia, with and without Helicobacter pylori infection.
FEMS Immunology and Medical Microbiology.2005;44:233–8.
10. Koskensalo S, Mrena J, Wiksten JP, Nordling S, Kokkola A, Hagstrom J, et
al, 2010. MMP-7 overexpression is an independent prognostic marker in
gastric cancer. Tumor Biol. (2010) 31: 149-155
11. Caruso R, Fina D, Peluso I, Tosti C, Blanco GDV, et al. IL-21Is Highly
Produced in Helicobacter pylori- Infected Gastritis Mucosa and Promotes
Gelatinases Synthesis J Immunol 2007;178: 5957-5965
12. Zhang Qiong-Wen, Liu Lei, Chen Ru, Wei Yu-Quan , Li Ping, Shi Hua-Shan
,
Zhao Yu-Wei.: Matrix Metalloproteinase-9 as a Prognostic Factor in Gastric
Cancer: A Meta-Analysis. Asian Pacific Journal of Prevention,vol 13,2012. P
2903-2908
13. Rhee Jae Won, Lee Keun-Wook, Kim Dongbum , Lee Younghee, Jeon OkHee,
Kwon Hyung-Joo , Kim Doo-Sik : 94 NF-κB-dependent Regulation of Matrix
Metalloproteinase-9 Gene Expression by Lipopolysaccharide in a Macrophage
Cell Line RAW 264.7. Journal of Biochemistry and Molecular Biology, Vol.
40, No. 1, January 2007, pp. 88-94
14. Toljamo K. Gastric erosions – clinical significance and pathology. A longterm follow-up study. University of Oulu, Finland:Acta Univ Oul; 2012.hlm
1-80.
15. Hirlan, Gastritis dalam Buku Ajar Ilmu Penyakit Dalam Edisi 5, Internal
Publishing : 2009 ; 509-512
16. S Iiyas. Repository.usu.ac.id.2013
17. Szoke D. Genetic factors related to the histological and macroscopic lesions
of the stomach. [disertasi]. Budapest: Semmelweis University; 2009. Hlm 761
18. Wehbi M. Acute gastritis. Medscape. 2014
Universitas Sumatera Utara
19. Rugge M, Pennelli G, Pilozzi E, Fassan M, Ingravallo G, Russo VM, et al.
Gastritis: the histology report. Digestive and Liver Disease. 2011; 43S:S373–
84.
20. Adibi P. Gastritis. [Diunduh 19 Mei 2014]. Tersedia dari: http://med.mui.ac.ir
21. Zakaria Z. The role of interleukin-10 in Helicobacter pylori infection. Master
[Tesis]. Nottingham,UK: University of Nottingham; 2010.hlm. 55.
22. Adam B, et al. Cellular immune activation and clinical manifestation of
funcional dyspepsia. Z Gastroenterol 2008;46-v26
23. Elseweidy MM. Helicobacter pylori ifection and its relevant to chronic
gastritis. INTECH.2013.http://dx.doi.org/105772/46056
24. Conteduca vincenza, domenico sansonno, gianfranco lauletta, sabino russi,
giuseppe ingravallo and franco dammacco. H. pylori infection and gastric
cancer: State of the art. international journal of oncology. 2013.42: 5-18.
25. D W, Chey, C B, Wong. American college of gastroenterology guidline on
the management of H.pylori infetion. Am J Gastroenterol 2007;102:18081825.
26. Simadibrata M. Dyspepsia and Gastroesophageal Reflux Disease (GERD): Is
There Any Correlation? Acta Med Indones. 2009; 41(4): 222-7.
27. Silva MIG, de Sousa FCF. Gastric ulcer etiology. In: Chai J, editor. Peptic
Ulcer Disease. Shanghai: Intech; 2011. hlm. 3-28.
28. Syam AF, Sadikin M, Wanandi SI, Rani AA. Molecular mechanism on
healing process of peptic ulcer. Acta Med Indones. 2009;41(2):95-8.
29. Brzozowski T. Experimental production of peptic ulcer, gastric damage and
cancer
models
pharmacological
and
their
use
treatment–polish
in
pathophysiological
achievement.
J
Phyl
studies
and
Pharmacol.
2003;54:99-126
30. Cheung R, Cheng TT, Dong Y, Lin HY, Lai K, Lau CS, et al. 2010. Incidence
of gastroduodenal ulcers during treatment with celecoxib or diclofenac:
pooled results from three 12-week trials in Chinese patients with osteoarthritis
or rheumatoid arthritis. Int J Rheum Dis;13(2): 151–7.
Universitas Sumatera Utara
31. Wallace JB. Prostaglandins, NSAIDs, and Gastric Mucosal Protection: Why
Doesn’t the Stomach Digest Itself? American Physiological Society. Physiol
Rev 88: 1547-1565, 2008Zhao X, Wang Q, Qian Y, Song JL,. Ilex kudingcha
C.J. Tseng (Kudingcha) prevents HCl/ethanol induced gastric injury in
Sprague Dawley rats. Molecular Medicine Reports. 2013;7:1613-6.
32. Mueller, A., et al., Profiling of microdissected gastric epithelial cells reveals
a
cell
type—specific
response
to
Helicobacter
pylori
infection.
Gastroenterology, 2004. 127(5): p. 1446-1462.
33. Fischer, W., et al., Systematic mutagenesis of the Helicobacter pylori cag
pathogenicity island: essential genes for CagA translocation in host cells and
induction of interleukin‐8. Molecular Microbiology, 2003. 47(6): p. 17591759.
34. Sundrud, M.S., et al., Inhibition of primary human T cell proliferation by
Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects
on IL-2 secretion. Proceedings of the National Academy of Sciences of the
United States of America, 2004. 101(20): p. 7727-7732.
35. Pelicic V, Reyrat JM, Sartori L, Pagliaccia C, Rappuoli R, Telford JL, et al.
Helicobacter pylori VacA cytotoxin associated with the bacteria increases
epithelial
permeability
independently
of
its
vacuolating
activity.
Microbiology. 1999;145(8): 2043-50.
36. Lu, H., et al., Duodenal ulcer promoting gene of Helicobacter pylori.
Gastroenterology, 2005. 128(4): p. 833-848.
37. Yamaoka, Y., et al., Helicobacter pylori outer membrane proteins and
gastroduodenal disease. Gut, 2006. 55(6): p. 775-781.
38. Rad, R., et al., The Helicobacter pylori blood group antigen-binding adhesin
facilitates bacterial colonization and augments a nonspecific immune
response. The Journal of Immunology, 2002. 168(6): p. 3033-3041.
39. Montecucco, C. and M. de Bernard, Molecular and cellular mechanisms of
action of the vacuolating cytotoxin (VacA) and neutrophil-activating protein
(HP-NAP) virulence factors of Helicobacter pylori. Microbes and infection,
2003. 5(8): p. 715-721.
Universitas Sumatera Utara
40. Chung HW, Lim JB, 2014. Role of the tumor microenvironment in the
pathogenesis of gastric carcinoma. World J Gastroenterol 2014; 20(7): 16671680
41. Tarnawski AS, Chai J, Jones MK. Esophageal and Gastrointestinal
Microcirculation: Essential for Mucosal Protection, a Target for Injury, and a
Critical Component of Injury and Ulcer Healing. In: Ishii H, Suematsu M,
Tanishita K, editor. Organ microcirculation: a gateway to diagnostic and
therapeutic intervention. Tokyo: Springer; 2005. Hlm 49-61.
42. Zhao X, Wang Q, Qian Y, Song JL,. Ilex kudingcha C.J. Tseng (Kudingcha)
prevents HCl/ethanol induced gastric injury in Sprague Dawley rats.
Molecular Medicine Reports. 2013;7:1613-6.
43. Tanigawa T, Watanabe T, Higuchi K, Machida H, Okazaki H, Yamagami H,
Watanabe K, Tominaga K, Fujiwara Y, Oshitani N, et al: Lansoprazole, a
Proton Pump Inhibitor, Suppresses Production of Tumor Necrosis
Factoralpha and Interleukin-1beta Induced by Lipopolysaccharide and
Helicobacter Pylori Bacterial Components in Human Monocytic Cells via
Inhibition of Activation of Nuclear Factor-kappaB and Extracellular SignalRegulated Kinase. J Clin Biochem Nutr. 2009, 45(1):86–92.
44. Lee HJ, Han YM, Kim EH, Kim YJ, Hahm KB. A possible involvement of
Nrf2-mediated heme oxygenase-1 up-regulation in protective effect of the
proton pump inhibitor pantoprazole against indomethacin-induced gastric
damage in rats. BMC Gastroenterology. 2012;12:143Bradley JR. TNFmediated inflammatory disease. J Pathol. 2008; 214:149-60.
45. Rakananurak N, Sallapant S, Prueksapanich P, Somanawat K, Klaikaew N,
Rerknimitr R, et al. Aloe vera Improved Gastric Injury on Nonsteroidal AntiInflammatory Drugs-Induced Gastropathy in Rats. Thai J Gastroenterol.
2013; 14(2):87-92.
46. Eamlamnam K, Patumraj S, Visedopas N, et al. Effects of Aloe vera and
sucralfate on gastric microcirculatory changes, cytokine levels and gastric
ulcer healing in rats. World J Gastroenterol. 2006;12:2034-9.
Universitas Sumatera Utara
47. Naito Y, Yoshikawa T, Yagi N, Matsuyama K, Yoshida N, Seto K, et al.
Effects of polaprezinc on lipid peroxidation, neutrophil accumulation, and
TNF- expression in rats with aspirin-induced gastric mucosal injury. Dig Dis
Sci. 2001;46:845–51.
48. Jainu M, Devi CSS. Gastroprotective action of Cissus quadrangularis extract
against NSAID induced gastric ulcer: role of proinflammatory cytokines and
oxidative damage. Chem Biol Interact. 2006;161:262–70
49. Konturek PC, Duda A, Brzozowski T, Konturek SJ, Kwiecien S, Drozdowicz
D, et al. Activation of genes for superoxide dismutase, interleukin-1beta,
tumor necrosis factor-alpha, and intercellular adhesion molecule-1 during
healing of ischemia-reperfusion-induced gastric injury. Scand J Gastroenterol.
2000;35(5):452-63
50. Fox JG, Wang TC. Inflammation, atrophy and gastric cancer. The Journal of
Clinical
51. Israel DA, Peek RM. Review article: Pathogenesis of Helicobacter pyloriinduced gastric inflammation. Aliment Pharmacol Ther. 2001;15:1271-90.
52. Bodger K, Crabtree JE. Helicobacter pylori and gastric inflammation. British
Med Bull. 1998;54:139-50
53. Furuta T, El-Omar EM, Xiao F, Shirai N, Takashima M, Sugimura H.
Interleukin 1beta polymorphisms increase risk of hypochlorhydria and
atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan.
Gastroenterology. 2002;123(1):92-105
54. Holck S, Norgaard A, Bennedsen M, Permin H, Norn S, Andersen LP, et al.
Gastric mucosal cytokine responses in Helicobacter pylori-infected patients
with gastritis and peptic ulcers. Association with inflammatory parameters
and bacteria load. FEMS Immunology and Medical Microbiology.
2003;36:175-80.
55. Schottelius AJ, Mayo MW, Sartor RB, Baldwin AS. Interleukin-10 signaling
blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA
binding. J Biol Chem. 1999;274:31868-74
Universitas Sumatera Utara
56. Al-Ashy R, Chakroun I, El-Sabban ME, Homaidan FR. The role of NFkappaB in mediating the anti-inflammatory effects of IL-10 in intestinal
epithelial cells. Cytokine. 2006; 36:1-8.
57. Kriskova S, Zitka O, Masarik M et al. Clinical Importance of matrix
metalloproteinases. Bratisl Lek Listy 2011;112(8):435-440
58. Amalinei C, Caruntu ID, Giusca SE et all. Matrix metalloproteinases
involvement in pathologic conditions. Romanian Journal of Morphology and
Embryology 2010, 51(2):215–228.
59. Verma RP,
Hansch C. Matrix metalloproteinases (MMPs): Chemical–
biological functions and (Q)SARs. Bioorganic & Medicinal Chemistry.
Volume 15, Issue 6, 15 March 2007, Pages 2223–2268.
60. Angulo JC, Ferruelo A, Barbero JMR et al. Detection and molecular staging
of bladder cancer using real-time RT-PCR for gelatinases (MMP-2, MMP-9)
and TIMP-2 in peripheral blood. Actas Urológicas Españolas (English
Edition). Volume 35, Issue 3, 2011,127–136.
61. Sampieri CL, Cordoba KL, Troche JMR, 2013.Matrix metalloproteinases and
their tissue inhibitors in gastric cancer as molecular markers. Review
Article.Journal of Cancer Research and Therapeutics, 2013.Volume 9-Issue 3.
62. Decocks J, Paridaens R, Ye S. Genetic polymorphisms of matrix
metalloproteinases in lung, breast and colorectal cancer. Clinical Genetics,
An International Journal of Genetics, Molecular and Personalized Medicine.
Volume 73, Issue 3, pages 197–211, March 2008
63. Charoenrat PO, Rhys-Evans PH, Eccles SA. Expression of Matrix
Metalloproteinases and Their Inhibitors Correlates With Invasion and
Metastasis in Squamous Cell Carcinoma of the Head and Neck. Arch
Otolaryngol Head Neck Surg. 2001;127(7):813-820
64. Mairi Macarthur, Georgina L. Hold, and Emad M. El-Omar. 2004.
Inflammation and Cancer. II. Role of chronic inflammation and cytokine gene
polymorphisms in the pathogenesis of gastrointestinal malignancy. Am J
Physiol
Gastrointest
Liver
Physiol
286:
G515-G520,
2004;
10.1152/ajpgi.00475.2003
Universitas Sumatera Utara
65. Musumba C, Pritchard DM, Primohamed M : Cellular and molecular
mechanisms of NSAID-induces peptic ulcers. Alimentary Pharmacology and
Therapeutics 30,2009. Blackwell Publishing . p517-531
66. Detrick, B., C. Nagineni, and J. Hooks, Cytokines: Regulators of Immune
Responses and Key Therapeutic Targets In: MRGOGaAD Donnenberg.
Human Immunology, CRC Press, Taylor & Francis Group, 2008: p. 495-516
67. Baratawidjaja KG. Imunologi Dasar: Sitokin. Jakarta: Balai Penerbit FK-UI;
2004. hlm. 128-31
68. Bradley JR. TNF-mediated inflammatory disease. J Pathol. 2008; 214:149-60.
69. Genersch Elke, Hayeß Katrin, Neuenfeld Yvette and Haller Hermann.
Sustained ERK phosphorylation is necessary but not sufficient for MMP-9
regulation in endothelial cells: involvement of Ras-dependent andindependent pathways. Journal of Cell Science 113, 4319-4330 (2000) 4319
Printed in Great Britain © The Company of Biologists Limited 2000
JCS1673
70. Amieva MR, Salama NR, Tompikns LS and Falkov S. Helicobacter pylori
Enter and Survive within Multivesiculer Vacuoles of Ephithelial Cells.
Cellular Mikrobiology. 2002; 4(10):677
71. Visse R and Nagase H. Matrix Metalloproteinase and Tissue Inhibitors of
Metalloproteinase;
Stucture,
Function,
and
Biochemistry.
Circulation
Research. 2003;8:827-839
72. Gibbs D.F. Warner R.L. , Weiss S. J., Johnson K.J., Varani J. 1999.
Characterization of Matrix Metalloproteinases Products by Rat Alveolar
macrophages . Am.J. Respir. Cell Moll . Biol. 20(6), 1136-1144.
73. Garg B, Sandhu V, Sood N, Sood A, Malhotra V. Histopathological analysis
of chronic gastritis and correlation of pathological features with each other
and with endoscopic findings. Pol J Pathol. 2012;3:172-8.
74. Chen H, Ying L, Kong M, Zhang Y, Li Y. The Prevalence of Helicobacter
pylori
Infection
Decreases
Gastritis. Gastroenterology
with
Older
Research
Age
and
in
Atrophic
Practice.
2013:Aug;21(2013)http://dx.doi.org/10.1155/2013/494783
Universitas Sumatera Utara
75. Pandeya N, Whiteman DC, Australian Cancer Study. Prevalence and
determinants of Helicobacter pylori sero-positivity in the Australian adult
community. J Gastroenterology Hepatology.2011 ;Aug;26(8):1283-9
76. Betty. Infeksi Helicobacter pylori pada lesi gastritis yang didiagnosa dengan
Pewarnaan Histokimia Giemsa dan Imunohistokimia Helicobacter pylori di
Laboratorium Patologi Anatomi Fakultas Kedokteran USU Medan. 2012.
http://repository.usu.ac.id/handle/123456789/34694
77. Parameswaran I, Hubungan peningkatan kadar leukosit dan neutropil dengan
infeksi
H.pylori
di
RSU
Permata
Bunda
Medan.2014.
http://repository.usu.ac.id/handle/123456789/41610.
78. Zho Y, et al. Risk factors and prevalence of H.Pylori infection in persistent
high incidence area of gastric carcinoma in Yangzhong city.2014.
http://dx.doi.org/10.1155/2014/481365
79. Naja F,et al. Helicobacter pylori in Ontario : prevalence and rsik factors.Jurnal
canadian of gastroenterologi. 2007:21(8):501-506
80. Abidiev S, Ahn KS, Khadjibaev A, Malikov Y, Bahramov S, Rakhimov B, et
al. Helicobacter pylori infection and cytokine gene polymorphisms in Uzbeks.
Nagoya J Med Sci, 2010;72:167-72
81. Salama NR, Hartung ML, Müller Anne. Life in the human stomach:
persistence strategies of the bacterial pathogen Helicobacter pylori. Nature
Reveiws Microbiol. 2013;11:385-99
82. Hoyer KK, Dooms H, Barron L, Abbas AK. Interleukin-2 in the development
and control of inflammatory disease. Immun Reviews. 2008; 226:19-28
83. Bamford KB, Fan X, Crowe SE, Leary JF, Gourley WK, Luthra GK, et al.
Lymphocytes in the human gastric mucosa during Helicobacter pylori have a
T helper cell 1 phenotype. Gastroenterol, 1998;114(3):482-92.
84. F.J.G.M. Kubben, C.F.M. Sier, M. Schram, A.M.C. Witte1, R.A. Veenendaal,
W. van Duijn, J.H. Verheijen, R. Hanemaaijer, C.B.H.W. Lamers, H.W.
Verspaget. Eradication of Helicobacter pylori infection favourably a ects
altered gastric mucosal MMP-9 levels. TNO Quality of Life, Biomedical
Research, Leiden, The Netherlands. Chapter 3. Helicobacter 2007, in press
Universitas Sumatera Utara
85. Adam B, et al. Cellular immune activation and clinical manifestation of
funcional dyspepsia. Z Gastroenterol 2008;46-v26
86. Joshi A, Gupta SD, Ahuja V, Sharma MP. Symptom score does not correlate
with gastritis grade and Helicobacter pylori infection in non ulcer dyspepsia.
Trop Gastroenterol 2001;22:194-6.
87. Sen Lin Li, Jing Run Zhao, Xiao Yan Ren, Jia Ping Xie, Qing Zhu Ma, Qiu
Hua Rong. Increased expression of matrix metalloproteinase-9 assosiated with
gastric ulcer recurren. World J Gastroenterol 2013;(28)19:4590-5.
Universitas Sumatera Utara